Lei Wang, MD, PhD
Director and Professor
Coronary Microvascular Disease Lab
The Second Affiliated Hospital
Guangzhou University of Chinese Medicine
Guangdong, China
Awarded “Outstanding Young Scholar of Chinese Medicine in Guangdong Province”

Selected publication
[1] Yangwen Ou, Cuiping Zhang, Miaoen Yao, Lei Wang. Gut flora: Novel therapeutic target of Chinese Medicine for the treatment of cardiovascular diseases. Evidence-Based Complementary and Alternative Medicine, 2019, ID3719596
[2] Shuai Mao, Lei Wang, Peipei Chen, et al. Nanoparticle-mediated delivery of Tanshinone IIA reduces adverse cardiac remodeling following myocardial infarctions in a mice model: role of NF-κB pathway. Artificial Cells, Nanomedicine, and Biotechnology, DOI: 10.1080/ 21691401. 2018,150802.
[3] Ma H, Chen P, Sang C, Huang D, Geng Q, Wang L. Modulation of apoptosis‐related microRNAs following myocardial infarction in fat-1 transgenic mice vs wild‐type mice. J Cell Mol Med. 2018;00:1–10.
[4] Tachibana, A., Santoso, M. R., Mahmoudi, M., Shukla, P., Wang, L., & Bennett, M., et al. Paracrine Effects of the Pluripotent Stem Cell-Derived Cardiac Myocytes Salvage the Injured Myocardium. Circulation Research, 2017, 121(6):22-36
[5] Mao S, Wang L, Ouyang W, Zhou Y, Qi J, Guo L, Zhang M, Hinek A.Traditional Chinese medicine, Danlou tablets alleviate adverse left ventricular remodeling after myocardial infarction: results of a double-blind, randomized, placebo-controlled, pilot study. BMC Complement Altern Med. 2016 ,16(1):447.
[6] Lei Wang, Xujie Zhao, Shuai Mao, et al.Efficacy of Danlou Tablet in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention:results from a multicenter, placebo-controlled, randomized trial. Evidence-Based Complementary and Alternative Medicine, 2016, 2016：7960503.
[7] Liao P, Wang L, Guo L, et al. Danhong Injection (a Traditional Chinese Patent Medicine) for Acute Myocardial Infarction: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med. 2015;2015:646530
[8] Wang L, Mao S, Qi JY, et al.Effect of Danlou Tablet on peri-procedural myocardial injury among patients undergoing percutaneous coronary intervention for non-ST elevation acute coronary syndrome: A study protocol of a multicenter, randomized, controlled trial. Chin J Integr Med. 2015，21（9）：662-666 (IF: 1.22)
[9] Shuai Mao, Lei Wang, Minzhou Zhang,et al. Sodium tanshinone IIA sulfonate for reduction of periprocedural myocardial injury during percutaneous coronary intervention (STAMP trial): Rationale and design. International Journal of Cardiology. 2015, 1 (182): 329-333.
[10] Lei Wang,Minzhou Zhang,Liheng,Guo,et al.Clinical Pathways Based on Integrative Medicine in Chinese Hospitals Improve Treatment Outcomes for Patients with Acute Myocardial Infarction: A Multi-centre, Non-Randomized Historically Controlled Trial. Evidence-Based Complementary and Alternative Medicine.2012, ID821641
[11] Wang Lei, Zhang Minzhou,Yang Guang. Combined therapy with Chinese Medicine and percutaneous transradial coronary intervention for a centenarian patient with acute myocardial infarction. Chin J Integr Med.2009,15(3)233-235